Blau Farmacêutica
Blau Farmacêutica is a publicly traded Brazilian multinational that specializes in high‑complexity, innovative pharmaceuticals for institutional and hospital ma
Company facts
- Founded
- 1987
- Employees
- 5,000
- Headquarters
- Brazil
- Type
- Enterprise
About
Blau Farmacêutica is a publicly traded Brazilian multinational that specializes in high‑complexity, innovative pharmaceuticals for institutional and hospital markets. Listed on B3 under the ticker BLAU3, the company develops and manufactures its own portfolio of drugs across therapeutic areas such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and botulinum toxin. Blau operates five state‑of‑the‑art manufacturing facilities and an active pharmaceutical ingredient (API) plant in Brazil, adhering to stringent international Good Manufacturing Practices. It serves patients throughout Latin America—including Argentina, Chile, Colombia, Ecuador, Mexico, Peru, and Uruguay—and the United States via its Hemarus plasma collection centers, positioning itself as a leading biotech-driven pharmaceutical provider.